Shin Nippon Biomedical Laboratories, Ltd. (TYO:2395)
1,092.00
-13.00 (-1.18%)
Jun 4, 2026, 3:30 PM JST
TYO:2395 Balance Sheet
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 18,371 | 12,032 | 10,274 | 10,533 | 6,628 |
Short-Term Investments | 165.22 | - | 336 | - | 368 |
Cash & Short-Term Investments | 18,536 | 12,032 | 10,610 | 10,533 | 6,996 |
Cash Growth | 54.06% | 13.40% | 0.73% | 50.56% | -3.97% |
Receivables | 7,133 | 6,513 | 5,722 | 4,695 | 3,499 |
Inventory | 15,114 | 12,618 | 12,373 | 7,329 | 4,359 |
Other Current Assets | 2,206 | 1,776 | 2,132 | 1,342 | 1,280 |
Total Current Assets | 42,989 | 32,939 | 30,837 | 23,899 | 16,134 |
Property, Plant & Equipment | 36,202 | 34,832 | 26,357 | 18,879 | 13,155 |
Long-Term Investments | 21,373 | 20,469 | 15,926 | 12,404 | 8,645 |
Goodwill | 1,763 | 1,884 | 1,934 | 1,438 | - |
Other Intangible Assets | 359.69 | 219 | 225 | 261 | 212 |
Long-Term Deferred Tax Assets | 1,552 | 2,036 | 989 | 325 | 1,129 |
Other Long-Term Assets | 784.82 | 2 | 2 | 2 | 1 |
Total Assets | 105,056 | 92,416 | 76,302 | 57,242 | 39,312 |
Accounts Payable | 406.87 | 460 | 460 | 419 | 64 |
Short-Term Debt | 19,670 | 11,777 | 7,826 | 8,923 | 2,942 |
Current Income Taxes Payable | 966.2 | 2,217 | 1,701 | 603 | 743 |
Other Current Liabilities | 18,282 | 14,802 | 13,580 | 11,066 | 9,624 |
Total Current Liabilities | 39,325 | 29,256 | 23,567 | 21,011 | 13,373 |
Long-Term Debt | 21,121 | 22,271 | 18,147 | 9,480 | 5,809 |
Long-Term Leases | 468.12 | 425 | 212 | 357 | 385 |
Long-Term Deferred Tax Liabilities | 481.44 | 235 | 84 | - | - |
Other Long-Term Liabilities | 170.37 | 145 | 133 | 36 | 22 |
Total Liabilities | 61,566 | 52,332 | 42,143 | 30,884 | 19,589 |
Common Stock | 9,679 | 9,679 | 9,679 | 9,679 | 9,679 |
Additional Paid-In Capital | 2,399 | 2,358 | 2,358 | 2,306 | 2,306 |
Retained Earnings | 22,573 | 20,087 | 17,215 | 13,766 | 10,196 |
Treasury Stock | -0.78 | - | - | - | - |
Comprehensive Income & Other | 8,471 | 7,898 | 4,861 | 460 | -2,620 |
Total Common Equity | 43,121 | 40,022 | 34,113 | 26,211 | 19,561 |
Minority Interest | 368.49 | 62 | 46 | 147 | 162 |
Shareholders' Equity | 43,489 | 40,084 | 34,159 | 26,358 | 19,723 |
Total Liabilities & Equity | 105,056 | 92,416 | 76,302 | 57,242 | 39,312 |
Total Debt | 41,259 | 34,473 | 26,185 | 18,760 | 9,136 |
Net Cash (Debt) | -22,723 | -22,441 | -15,575 | -8,227 | -2,140 |
Net Cash Per Share | -545.80 | -539.05 | -374.12 | -197.62 | -51.40 |
Filing Date Shares Outstanding | 41.63 | 41.63 | 41.63 | 41.63 | 41.63 |
Total Common Shares Outstanding | 41.63 | 41.63 | 41.63 | 41.63 | 41.63 |
Working Capital | 3,663 | 3,683 | 7,270 | 2,888 | 2,761 |
Book Value Per Share | 1035.76 | 961.33 | 819.40 | 629.59 | 469.85 |
Tangible Book Value | 40,998 | 37,919 | 31,954 | 24,512 | 19,349 |
Tangible Book Value Per Share | 984.78 | 910.82 | 767.54 | 588.78 | 464.76 |
Land | 5,033 | - | - | - | - |
Buildings | 41,988 | - | - | - | - |
Machinery | 12,152 | - | - | - | - |
Construction In Progress | 1,816 | - | - | - | - |
Order Backlog | 40,920 | 35,690 | 34,404 | 29,249 | 19,724 |